Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
-
2020/08/20
-
Details
-
Personal Author:Ahmed A ; Aleckovic M ; Ambati SR ; Ararso Y ; Bailey KA ; Balachandran VP ; Basu EM ; Batra SK ; Benito-Martin A ; Berger M ; Bojmar L ; Brady MS ; Buehring W ; Cardoso F ; Chou AJ ; Cioffi M ; Danzer E ; Davies AE ; De Braganca KC ; DeStefano J ; Di Giannatale A ; Diolaiti D ; Donzelli M ; Fischer C ; Freitas D ; Ganshaw L ; García-Santos G ; Ghajar CM ; Gyan KE ; Harris A ; Hashimoto A ; Heissel S ; Hernandez J ; Hoshino A ; Jain M ; Jolissant JS ; Kenific CM ; Khakoo Y ; Kim HS ; Krantz BA ; Lacayo NJ ; Lauritzen P ; Lucotti S ; Malladi M ; Mark MT ; Marrano M ; Meyers PA ; Modak S ; Molina H ; Nakajima M ; Nogués L ; Offer K ; Ogitani Y ; Oren M ; Pelissier Vatter FA ; Petriccione M ; Posner Z ; Raju GP ; Roberts SS ; Rodrigues G ; Roehrl MHA ; Rudin CM ; Sagi I ; Schaeffer LM ; Scherz A ; Scherz-Shouval R ; Simeone DM ; Simpson AL ; Slotkin EK ; Stanger BZ ; Steiner L ; Sugiura K ; Takahashi N ; Vincent TC ; Vitolano S ; Wang H ; Weiser MR ; Wexler LH ; Williams C ; Wright GP ; Yarden Y ; Zambirinis CP
-
Description:There is an unmet clinical need for improved tissue and liquid biopsy tools for cancer detection. We investigated the proteomic profile of extracellular vesicles and particles (EVPs) in 426 human samples from tissue explants (TEs), plasma, and other bodily fluids. Among traditional exosome markers, CD9, HSPA8, ALIX, and HSP90AB1 represent pan-EVP markers, while ACTB, MSN, and RAP1B are novel pan-EVP markers. To confirm that EVPs are ideal diagnostic tools, we analyzed proteomes of TE- (n = 151) and plasma-derived (n = 120) EVPs. Comparison of TE EVPs identified proteins (e.g., VCAN, TNC, and THBS2) that distinguish tumors from normal tissues with 90% sensitivity/94% specificity. Machine-learning classification of plasma-derived EVP cargo, including immunoglobulins, revealed 95% sensitivity/90% specificity in detecting cancer. Finally, we defined a panel of tumor-type-specific EVP proteins in TEs and plasma, which can classify tumors of unknown primary origin. Thus, EVP proteins can serve as reliable biomarkers for cancer detection and determining cancer type. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0092-8674
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:California ; Maryland ; Nebraska ; New Jersey ; New York ; Ohio ; OSHA Region 1 ; OSHA Region 10 ; OSHA Region 2 ; OSHA Region 3 ; OSHA Region 5 ; OSHA Region 7 ; OSHA Region 9 ; Pennsylvania ; Vermont ; Washington
-
CIO:
-
Topic:
-
Location:
-
Volume:182
-
Issue:4
-
NIOSHTIC Number:nn:20061652
-
Citation:Cell 2020 Aug; 182(4):1044-1061.e18
-
Contact Point Address:Ayuko Hoshino, Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA
-
Email:ayukohoshino@bio.titech.ac.jp
-
Federal Fiscal Year:2020
-
NORA Priority Area:
-
Performing Organization:University of Pittsburgh at Pittsburgh
-
Peer Reviewed:True
-
Start Date:20060901
-
Source Full Name:Cell
-
End Date:20260831
-
Collection(s):
-
Main Document Checksum:urn:sha-512:cd7eee5f54ad49257e03f432f4f7e106448aff0c3e823c4878af0262571c724abc6b3ff618ac353e6de69883b44f233d51e9913d0f6bb2e08f283784190f97f4
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like